Joshua M. Wilson - 29 Nov 2022 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)

Role
Director
Signature
/s/ Erika L. Eves for Joshua M. Wilson, by power of attorney
Issuer symbol
NAVB
Transactions as of
29 Nov 2022
Transactions value $
$30
Form type
4
Filing time
30 Nov 2022, 15:12:31 UTC
Previous filing
25 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $30.00 +30K $0.00* 30K 29 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest as to one-third on each of the first three anniversaries of the date of grant.